ctrl K

Price Alert

Structure Therapeutics In... (GPCR)

NASDAQ: GPCR · Real-Time Price · USD

19.61

1.08 (5.83%)

At close: Aug 15, 2025, 11:14 AM

Structure Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	169.51M	129.79M	90.84M	105.31K
Short-Term Investments	714.01M	337.53M	64.75M	2K
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	5.11M	45K	3.46M	111.00
Receivables	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	7.69M	6.29M	2.25M	n/a
Total Current Assets	891.21M	473.61M	93.09M	109.25K
Property-Plant & Equipment	7.01M	8.36M	1.29M	1.79K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	12.12M	8.41M	4.76M	1.91K
Total Assets	903.33M	482.02M	97.84M	111.16K
Account Payables	8.02M	4.74M	6.01M	3.48M
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	260K	n/a
Other Current Liabilities	19.01M	13.88M	3.28M	-8.42M
Total Current Liabilities	36.02M	24.74M	13.01M	8.66K
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	302K	298K	n/a	-104.77K
Total Long-Term Liabilities	2.47M	4.31M	199.97M	167.23K
Total Liabilities	38.49M	29.05M	212.99M	175.89K
Total Debt	3.86M	5.45M	260K	621.00
Common Stock	17K	14K	1K	n/a
Retained Earnings	-329.1M	-206.57M	-116.95M	-64.74K
Comprehensive Income	914K	521K	-110K	-166.96M
Shareholders Equity	864.84M	452.97M	-115.14M	-64.73K
Total Investments	714.01M	337.53M	64.75M	2K